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Abstract
The faster drugs of abuse reach the brain, the greater is the risk of addiction. Even small differences in the rate of drug delivery
can influence outcome. Infusing cocaine intravenously over 5 vs. 90–100 s promotes sensitization to the psychomotor and incen-
tive motivational effects of the drug and preferentially recruits mesocorticolimbic regions. It remains unclear whether these effects
are due to differences in how fast and/or how much drug reaches the brain. Here, we predicted that varying the rate of intra-
venous cocaine infusion between 5 and 90 s produces different rates of rise of brain drug concentrations, while producing similar
peak concentrations. Freely moving male Wistar rats received acute intravenous cocaine infusions (2.0 mg/kg/infusion) over 5, 45
and 90 s. We measured cocaine concentrations in the dorsal striatum using rapid-sampling microdialysis (1 sample/min) and
high-performance liquid chromatography-tandem mass spectrometry. We also measured extracellular concentrations of dopamine
and other neurochemicals. Regardless of infusion rate, acute cocaine did not change concentrations of non-dopaminergic neuro-
chemicals. Infusion rate did not significantly influence peak concentrations of cocaine or dopamine, but concentrations increased
faster following 5-s infusions. We also assessed psychomotor activity as a function of cocaine infusion rate. Infusion rate did not
significantly influence total locomotion, but locomotion increased earlier following 5-s infusions. Thus, small differences in the rate
of cocaine delivery influence both the rate of rise of drug and dopamine concentrations, and psychomotor activity. A faster rate of
rise of drug and dopamine concentrations might be an important issue in making rapidly delivered cocaine more addictive.
Introduction
The rate of drug delivery to the brain is important in determining
the risk of developing addiction. For instance, smoking cocaine or
injecting the drug intravenously is associated with a greater vulnera-
bility to addiction than intranasal use (Gossop et al., 1994; Hat-
sukami & Fischman, 1996). After smoking or intravenous (i.v.)
infusion, plasma cocaine concentrations rise more rapidly and reach
higher peaks than after intranasal administration (Javaid et al., 1978;
Jeffcoat et al., 1989; Jones, 1990). Such pharmacokinetic differences
are important in determining outcome. For instance, different phar-
macokinetic profiles are one reason why the same drug can lead to
addiction when taken by one route (nicotine inhaled from tobacco
smoke) but can treat addiction when taken by another (nicotine
administered orally from a gum or through the skin from a patch,
Henningfield & Keenan, 1993).
Varying the rate of drug delivery to the brain influences the psy-
chological and behavioural effects of drugs. In humans, cocaine
(Resnick et al., 1977) and heroin (Comer et al., 1999) evoke more
immediate and stronger pleasurable effects when administered i.v.
rather than intranasally. Similarly, increasing the rate of i.v. cocaine
(Fischman & Schuster, 1984; Abreu et al., 2001) or morphine
(Marsch et al., 2001) infusion produces greater self-reports of
euphoria. Early studies in laboratory animals show that relatively
large variations in the rate of i.v. drug administration (i.e., injecting
a dose between 5–600 s) influence cocaine self-administration beha-
viour (Balster & Schuster, 1973; Woolverton & Wang, 2004). More
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recent experiments have explored the effects of varying the rate of
i.v. infusion over a smaller range of time (5–100 s). Doing so is
important for three main reasons. First, experienced i.v. cocaine
users report that they inject the drug rapidly and over a narrow
range (3–10 s, Zernig et al., 2003). Second, the time difference in
the onset of subjective drug effects in i.v. vs. intranasal cocaine
users is also narrow (2–9 s, Zernig et al., 2003 and 30–120 s,
Jones, 1984; Weiss et al., 1993, respectively). Finally, injecting
cocaine i.v. over 2 vs. 60 s influences the magnitude of subjective
cocaine effects in humans (Abreu et al., 2001). Such small differ-
ences in the rate of drug delivery can have large effects on beha-
viour in laboratory rats. For instance, injecting cocaine or nicotine
i.v. over 5 vs. 90–100 s promotes sensitization to the psychomotor
(Samaha et al., 2002, 2004; Samaha & Robinson, 2005; Allain
et al., 2017) and incentive motivational effects of these drugs (Liu
et al., 2005; Minogianis et al., 2013; Bouayad-Gervais et al., 2014;
Allain et al., 2017). Rats that self-administer i.v. cocaine injections
delivered over 5 vs. 90 s also take more drug (Wakabayashi et al.,
2010; Minogianis et al., 2013; Bouayad-Gervais et al., 2014), and
are more susceptible to relapse following extended abstinence (Wak-
abayashi et al., 2010).
Variation in the rate of drug delivery influences behaviour pre-
sumably because it changes the neurobiological impact of drugs.
Studies in rats show that increasing the rate of cocaine delivery to
the brain enhances cellular activity in mesocorticolimbic areas (re-
viewed in Samaha & Robinson, 2005). A first study showed that
compared to intraperitoneal cocaine, i.v. cocaine enhances glucose
utilization in corticolimbic regions (Porrino, 1993). More recent
work shows that injecting cocaine i.v. over 5 vs. 90–100 s increases
drug-induced immediate early gene expression (Samaha et al.,
2004), heat-producing metabolic activity (Brown & Kiyatkin, 2005),
and regulation of the growth factor, brain-derived neurotrophic fac-
tor and its receptor TrkB (Bouayad-Gervais et al., 2014). Chronic
intake of i.v. infusions of cocaine delivered over 5 s but not over
90 s also increases the function of metabotropic group II receptors
in the prelimbic cortex and nucleus accumbens (Allain et al., 2017).
Thus, small differences in the rate of i.v. cocaine delivery can
predict outcome but is this due to how fast cocaine enters the brain,
peak concentration achieved, or both? This question remains unan-
swered because brain concentrations of cocaine have been modelled
(Samaha et al., 2002; Allain et al., 2017), but not actually measured
as a function of the rate of i.v. drug delivery. It is possible that
varying the rate of i.v. drug infusion, even over a small range, pro-
duces differences in achieved concentration, and this could con-
tribute to the effects seen on brain and behaviour. However, beyond
achieved dose, temporal pharmacokinetic variables such as how fast
drug levels rise can determine behavioural and neurobiological
effects relevant to addiction (Allain et al., 2015, 2017). The brain is
sensitive to the temporal pattern of cellular stimulation. For instance,
in a context outside of drugs of abuse, different temporal patterns of
electrical stimulation are differentially effective in producing long-
term potentiation (Larson & Lynch, 1986) and dopamine-evoked
synaptic plasticity (Wieland et al., 2015).
Here, we hypothesized that varying the rate of i.v. cocaine deliv-
ery between 5 and 90 s produces differences in the rate of rise of
striatal cocaine and dopamine concentrations, without producing
large effects on peak concentrations. We make this prediction first
because it is supported by pharmacokinetic modelling (Samaha
et al., 2002; Allain et al., 2017; where the pharmacokinetic model
was based on Pan et al., 1991). Second, dopamine and cocaine con-
centrations are tightly correlated in the brain (Nicolaysen et al.,
1988; Shou et al., 2006), and injecting cocaine i.v. over 5 vs. 100 s
produces differences in the rate of rise of extracellular dopamine
concentrations in the striatum, without affecting peak concentrations
(Ferrario et al., 2008 but see Samaha et al., 2004, where brief dif-
ferences in the half-life of electrically stimulated extracellular dopa-
mine were observed). To test our hypothesis, we injected freely
moving rats with i.v. infusions of cocaine delivered over 5, 45 and
90 s, and we used rapid-sampling (1 sample/min) microdialysis cou-
pled with high performance liquid chromatography-tandem mass
spectrometry (HPLC-MS/MS) to simultaneously measure cocaine
and dopamine concentrations in the dorsal striatum (DS). We mea-
sured dopamine concentrations because cocaine-induced increases in
dopamine overflow regulate the incentive motivational effects of the
drug. The microdialysis samples were also used to determine
cocaine effects on 20 other neurochemicals in the striatum. As an
additional functional measure, we assessed the psychomotor
response to acute cocaine infused over 5, 45 and 90 s, in a separate
cohort of rats. Based on prior work, we predicted that varying the
rate of cocaine delivery over this range would not influence the
magnitude of the locomotor response (Samaha et al., 2002), but that
rate could influence the time course of cocaine-induced locomotion.
Materials and methods
Animals and housing
Twenty male Wistar rats (seven for microdialysis and thirteen for
cocaine-induced psychomotor activity; Charles River Laboratories,
St-Constant, QC, Canada) weighing between 225 and 300 g upon
arrival were housed individually in a climate-controlled colony room
maintained on a reverse 12 h/12 h light/dark cycle (lights off at
8:30–9:00 am). Experiments were conducted during the dark phase
of the rats’ circadian cycle. Food and water were available ad libi-
tum. The animal care committees of the Universite de Montreal
(CDEA 14-149 and 17-095) and of Concordia University approved
all procedures involving animals. These procedures complied with
guidelines of the Canadian Council on Animal Care.
Surgery
Following 1–4 weeks of acclimatization to the vivarium, a custom-
made, indwelling catheter was implanted into the jugular vein of
rats anaesthetized with isoflurane (CDMV, Saint-Hyacinthe, QC,
Canada). The other end of the catheter was set to exit between the
scapulae. Animals to be used for in vivo microdialysis were then
placed in a stereotaxic apparatus and a cannula (21-gauge; HRS
Scientific, Montreal, QC, Canada) was implanted into the DS of
one hemisphere (counterbalanced across animals; coordinates rela-
tive to Bregma; anteroposterior, + 1.6 mm, mediolateral,
 2.5 mm, and dorsoventral, 3.0 mm). Cannulae were anchored
to the skull with jeweller’s screws, secured in place with dental
cement and sealed with obturators (22-gauge; HRS Scientific). We
targeted the DS because it is rich in dopamine transporters and it
mediates the expression of addiction-related behaviours (Everitt &
Robbins, 2005). At the time of surgery, rats received a subcuta-
neous injection of 5 mg/kg Carprofen (Rimadyl; 50 mg/mL;
CDMV) and an intramuscular injection of 0.02 mL of a penicillin
G procaine solution (Procillin; 300 000 IU/mL; CDMV). Intra-
venous catheters were flushed on alternate days with either 0.1 mL
physiological saline or a solution containing 0.2 mg/mL Heparin
(Sigma-Aldrich, Oakville, ON, Canada) and 2 mg/mL of the antibi-
otic Baytril (CDMV). Rats recovered in their home cages for
7 days prior to further manipulation.
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Determination of microdialysis probe delay time in vitro
A first goal was to measure the delay time between placement of
our microdialysis probes into a cocaine solution, and detection of
the drug in a collected sample. This is important, as it provides a
measure of the inevitable delay time that a sample needs to travel
from the microdialysis probe, through the tubing set-up and finally
into the sample collection vials. Two custom-made microdialysis
probes (described below) were perfused at 2 lL/min with artificial
cerebrospinal fluid (aCSF) containing 145 mM NaCl, 2.68 mM KCl,
1.40 mM CaCl2*2H2O, 1.01 mM MgSO4*7H2O, 1.55 mM Na2HPO4,
0.45 mM NaH2PO4*H2O in HPLC-grade water (pH = 7.4; chemicals
from Fisher Scientific, Saint-Laurent, QC, Canada; water from
Sigma Aldrich, Oakville, ON, Canada). Probes were first placed into
a beaker containing a stirred solution of aCSF and ascorbic acid
(0.25 mM) at room temperature. After 20 min, 10 samples were col-
lected at 1-min intervals. Probes were then transferred to a second
beaker containing aCSF + ascorbic acid solution and 1 lM cocaine,
from which 26 samples were taken. Finally, the probes were
returned to the aCSF + ascorbic acid solution and 16 additional
samples were collected. Samples were collected in 300-lL micro-
centrifuge vials (VWR, Montreal, QC, Canada), and immediately
placed in dry ice and stored at 80°C until analysis by HPLC-MS/
MS.
In vivo microdialysis probes
In vivo microdialysis was conducted in four custom-made hexagonal
chambers (42 9 39 9 33.5 cm) each placed within a larger sound-
and light-attenuating cabinet. Microdialysis probes were custom-
made. They consisted of a 1 cm length of semi-permeable dialysis
membrane (200 lm ID, 216 lm OD, with a molecular weight cut-
off of 13 kDa; VWR) that extended 4 mm below the tip of the
guide cannula. The membrane was inserted into a 20-mm length of
26G stainless steel tubing. The outer end of the membrane was
occluded with super glue to create a closed system for dialysate
flow. The stainless-steel shaft was inserted into one end of polyethy-
lene (PE) 20 tubing (0.38 mm ID, 1.09 mm OD; 65 cm long; Scien-
tific Commodities Inc., Lake Havasu City, AZ, USA), while the
other end was connected to a dual-channel liquid swivel (Lomir,
Notre-Dame-de-l’Ile-Perrot, QC, Canada). The swivel was in turn
connected to a syringe pump (Harvard Apparatus, Saint-Laurent,
QC, Canada) with PE-20 tubing. Small-diameter fused silica tubing
(41 lm ID, 110 lm OD; 2 cm long; HRS Scientific) extended into
the probe 0.5 mm from the glued tip of the semi-permeable mem-
brane. The other end of the fused silica was glued to PE-1 tubing
(0.127 mm ID, 0.254 mm OD; 60 cm long) that extended out of the
PE-20 tubing, serving as an outlet for the probe. The microdialysis
probe was secured to the cannula with a stainless-steel collar. The
relative recovery rates from the microdialysis probes were 10% for
cocaine and 8–15% for dopamine.
In vivo microdialysis experiment
Figure 1A illustrates the sequence of experimental events. Following
recovery from surgery, microdialysis rats were placed in the test
chambers for two, 3.5-h habituation sessions (one/day). Their cathe-
ters were tethered to the i.v. drug infusion line and their cannulae
were tethered to the steel spring casing used to protect the micro-
dialysis tubing during sampling. During each habituation session,
each rat received 78 lL of saline i.v. over 5, 45 and 90 s, with one
infusion given every 90 min in counter-balanced order. We injected
a volume of 78 lL because for cocaine injections, we would inject
34 lL of saline to account for average catheter volume + 10 lL
cocaine solution + 34 lL of saline to ensure that none of the
cocaine remains in the catheter. Catheter patency was verified on the
second habituation day by i.v. infusion of the short-acting barbitu-
rate, sodium thiopental (20 mg/mL in sterile water, 0.1–0.2 mL/rat;
CDMV). All rats became ataxic within 5 s of the infusion, confirm-
ing catheter patency. In rats, sodium thiopental has a T1/2 of ~4–5 h
(Shideman et al., 1953), thus we do not expect it to influence micro-
dialysis measurements performed on the next day. On the following
day, rats were placed in the test chambers and dialysis probes were
lowered into the striatum for a 5-h habituation period. During this
period, aCSF was perfused through the microdialysis probe at a rate
of 2.0 lL/min. Rats were awake and freely moving during the
experiment. Three hours and 50 min into the habituation period, ani-
mals were tethered to the cocaine infusion line. It contained 10 lL
of cocaine solution (Medisca Pharmaceutique Inc,
St-Laurent, QC, Canada; 2 mg/kg/infusion in 0.9% physiological
saline) separated from additional saline by a small air bubble. The
other end of the line was attached to a 3 c.c. BD syringe placed on
a syringe pump. A 2 mg/kg dose of cocaine is similar to doses used
in prior studies that have measured cocaine or dopamine concentra-
tions in the striatum using in vivo microdialysis (Hurd et al., 1988;
Hurd & Ungerstedt, 1989; Ferrario et al., 2008). This dose also
evokes robust immediate early gene expression in the DS (Samaha
et al., 2004).
Over the last 10 min of the 5-h habituation period, 10 baseline
dialysate samples were collected, at 1-min intervals and at a flow
rate of 2.0 lL/min, yielding 2.0 lL/sample. Next, each animal
received the first of three i.v. cocaine infusions (2.0 mg/kg/10 lL/
infusion), delivered over 5, 45 and 90 s, injected 90 min apart, in
counter-balanced order. Cocaine infusions were spaced 90 min
apart because this is 3–4 times longer than cocaine’s T1/2 in rat
brain (Nayak et al., 1976; Hurd et al., 1988). Thus, the 90-min
inter-infusion interval reduces the possibility of carry-over effects
between infusions (see also Hurd et al., 1988). Following each
cocaine infusion, 15 samples were collected, at 1-min intervals.
Five 1-min baseline samples were also collected prior to the 2nd
and 3rd cocaine infusions. Samples were collected in a 300-lL
polypropylene microsampling vial placed on the end of the outlet
line. Samples were immediately placed in dry ice and stored at
80°C until processing. At the end of sampling, each microdialy-
sis probe was visually inspected for leaks or breakage. None were
detected.
High performance liquid chromatography-tandem mass
spectrometry (HPLC-MS/MS)
Small molecule neurochemical analysis using a triple quadrupole
(QQQ) MS
All chemicals were from Sigma Aldrich (St. Louis, MO, USA) unless
noted otherwise. Water and acetonitrile for mobile phases were Bur-
dick & Jackson HPLC grade (VWR, Radnor, PA, USA). Artificial
CSF consisted of 145 mM NaCl, 2.68 mM KCl, 1.40 mM CaCl2,
1.01 mM MgSO4, 1.55 mM Na2HPO4, and 0.45 mM NaH2PO4,
adjusted pH to 7.4 with NaOH. Cocaine standards (Mallinckrodt Inc.,
St. Louis, MO, USA) were spiked into a standard mixture for a six-
point calibration curve. A modified LC-MS method (Song et al.,
2012; Wong et al., 2016) was used to quantify concentrations of
extracellular cocaine and dopamine, as well as acetylcholine, adeno-
sine, aspartate, 3,4-dihydroxyphenylacetic acid, c-aminobutaric acid,
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glutamate, glutamine, glucose, glycine, histamine, 5-hydroxyindolea-
cetic acid, homovanillic acid, 3-methoxytyramine, norepinephrine,
normetanephrine, phenylalanine, serine, serotonin, taurine, and tyro-
sine. Samples were thawed and derivatized with 1.5 lL sodium car-
bonate, 100 mM; 1.5 lL BzCl, 2% (v/v) BzCl in acetonitrile; 1.5 lL
isotopically labelled internal standard mixture diluted in 50% (v/v)
acetonitrile containing 1% (v/v) sulphuric acid, and spiked with
deuterated acetylcholine and choline (C/D/N isotopes, Pointe-Claire,
QC, Canada) to a final concentration of 20 nM. Derivatized samples
were analysed using Thermo Scientific Accela UHPLC system inter-
faced to a Thermo Scientific TSQ Quantum Ultra triple quadrupole
mass spectrometer fitted with a HESI II ESI probe, operating in multi-
ple reaction monitoring. Five-lL samples were injected onto a Phe-
nomenex core-shell biphenyl Kinetex HPLC column (1.7 lm
particles, 2.1 mm 9 100 mm). Mobile phase A was 10 mM ammo-
nium formate with 0.15% formic acid, and mobile phase B was ace-
tonitrile. Mass transitions for these derivatized analytes were reported
in Wong et al. (2016). Cocaine was detected in its native form with a
MS/MS transition of 304? 182 m/z. The mobile phase was delivered
through an elution gradient at 450 lL/min as follows: initial, 0% B;
0.01 min, 19% B; 1 min, 26% B; 1.5 min, 75% B; 2.5 min, 100% B;
3 min, 100% B; 3.1 min, 5% B; and 3.5 min, 5% B. THERMO XCALIBUR
QUANBROWSER (Thermo Fisher Scientific) software automatically pro-
cessed and integrated peaks. Each peak was visually inspected to
ensure proper integration. The limits of detection for cocaine and
dopamine after derivatization were 0.291 and 0.086 nM, respectively.
Limits of detection for the other analytes were 0.045–141 nM.
Histology
Following sampling, animals were anaesthetized with isoflurane and
decapitated. Brains were then extracted, frozen and stored at 80°C.
The neuroanatomical location of the probes was estimated on 20-lm
thick coronal brain sections, according to the rat brain atlas of Paxi-
nos & Watson (1986).
Psychomotor activity experiment
Figure 1B shows the sequence of experimental events. Locomotor
activity was assessed in four chambers (31.8 9 25.4 9 26.7 cm;
Med Associates, St-Albans, VT, USA), each containing four infrared
photocells aligned horizontally at the bottom of each cage. The
chambers were run by a computer using Med Associates Med-PC
version IV software (Med Associates). Following recovery from sur-
gery, rats were placed in the test chambers for two, 2-h habituation
sessions (one/day). Their catheters were tethered to the i.v. infusion
line and a steel spring casing used to protect the line during testing.
In the first habituation session, no i.v. infusion was given. During
the second habituation session, rats received saline i.v. over 5, 45 or
90 s, 30 min into the session. Following the end of this second
habituation session, catheter patency was verified by i.v. infusion of
Propofol (10 mg/mL; 0.1 mL/rat; CDMV), a short-acting anaesthetic
(T1/2 ~27 min in Wistar rats; Dutta et al., 1997). Sodium thiopental
was not used in this 2nd experiment because it was no longer avail-
able from the manufacturer. All rats became ataxic within 5 s of the
Propofol infusion, confirming catheter patency. On the next day,
animals were placed in the test chambers and tethered to an infusion
line containing the cocaine solution (2.0 mg/kg in 10 lL). The other
end of the line was attached to a 1 c.c. BD syringe and placed on a
microsyringe pump (HAVARD PHD, 2000; HARVARD Appara-
tus). Following a 30-min habituation period, each animal received
the first of three experimenter-administered i.v. cocaine infusions
delivered over 5, 45 or 90 s, injected 90 min apart and in counter-
balanced order. The test session lasted five hours, and locomotor
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probe lowered 
into guide cannula 
Microdialysis sampling
0:00 3:50 6:305:00 8:00
Time (in hours)
1 2 3
Rat tethered 
to cocaine 
infusion line 
4:50
Habituation to the microdialysis test chambers
a In vivo microdialysis experiment
b Psychomotor activity experiment
0:00
Time (in hours)
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to cocaine 
infusion line 
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to the 
locomotor 
cages
0:30 2:00 3:30
1 2 3
Legend: 
 = Beginning of cocaine infusion
 = 1-min baseline samples 
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Surgery  
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(7 days)
Acclimatization
to test 
procedures
Fig. 1. The sequence of experimental events. Panel (a) illustrates the timeline of experimental events for the in vivo microdialysis study. Rats were implanted
with a unilateral cannula into the dorsal striatum (DS) and a catheter into the jugular vein. Following recovery, the rats were habituated to the in vivo microdial-
ysis apparatus and to the i.v. infusion procedure on two daily sessions. On the following test day, microdialysis probes were inserted into the DS and i.v. cathe-
ters were tethered to the cocaine infusion set up. Each rat received an i.v. infusion of 2 mg/kg cocaine, delivered over 5, 45 or 90 s, in counterbalanced order,
with infusions administered 90 min apart. Dialysate samples were collected every minute for 5–10 min before each infusion and for 15 min thereafter.
Panel (b) shows the sequence of experimental events for the psychomotor activity study. Rats were implanted with an intrajugular catheter and allowed to
recover for 7 days. Rats were then habituated to the psychomotor activity cages and i.v. infusion lines on two daily sessions. On the following test day, rats
were tethered to the cocaine infusion lines and locomotor activity was measured. Each rat received i.v. cocaine (2.0 mg/kg/infusion) delivered over 5, 45 and
90 s, in counterbalanced order, with infusions administered 90 min apart.
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activity was recorded as photocell beam breaks, computed over 10-s
intervals. At the end of the study, catheter patency was verified once
again with Propofol and animals were immediately euthanized by
decapitation while still under anaesthesia. One rat did not become
ataxic and was eliminated from the study.
Statistical analysis
Data were analysed with PRISM 7 software (GraphPad Software Inc.,
La Jolla, CA, USA). Changes in cocaine concentration as a function
of time during the in vitro assay were analysed using one-way anal-
ysis of variance (ANOVA). Repeated measures two-way ANOVA was
used to analyse the effects of cocaine infusion rate on average extra-
cellular concentrations of cocaine and dopamine over time, and on
locomotor activity over time (‘Infusion Rate’ and ‘Time’ as within-
subjects variables). Repeated measures one-way ANOVA, followed by
Tukey’s multiple comparison tests or two-tailed paired t-tests, were
used to analyse the effects of cocaine infusion rate on cocaine and
dopamine Cmax (the highest value for each analyte obtained from
each rat after cocaine, averaged by infusion rate), Tmax (time to
reach Cmax in each rat, averaged by infusion rate), and time to first
significant increase (the first value > 2 standard deviations above
baseline in each rat, averaged by infusion rate). One-way ANOVA was
also used to assess the effects of cocaine infusion rate on both total
locomotor activity (from minute ‘0’ to minute ‘30’) and locomotor
activity within the first minute after injection. Linear regression was
used for the correlations and Fisher’s r-to-z transformation was then
used to compare correlation coefficients (r). Effects were considered
statistically significant when P < 0.05.
Results
Determination of microdialysis probe delay time in vitro
Figure 2 shows cocaine concentrations at 1-min intervals when
microdialysis probes were placed in an aCSF/ascorbic acid solution,
then in an aCSF/ascorbic acid/1 lM cocaine solution, and back
again. Of note, apparent cocaine concentrations do not start at or
return to ‘0’ when the probes are placed in the aCSF/ascorbic acid
solution, before and after probe immersion in the cocaine solution.
This background signal is likely produced by a contaminant with a
similar mass transition to cocaine. We overcame this issue by taking
the background contaminant signal into account when assigning the
lower limit of quantification (LLOQ) of the LC-MS assay. This
LLOQ was estimated as being 39 greater than the signal generated
in aCSF/ascorbic acid alone, or 23 nM. The baseline values in Fig. 2
are all below 23 nM and thus these values can be considered to be a
background signal. It is only when the dialysis probe is placed in
the cocaine-containing solution that cocaine concentrations rise
above the LLOQ. Once the microdialysis probes were placed into
the cocaine solution, cocaine concentrations increased significantly
from baseline levels (One-way ANOVA on minutes 10 to 26;
F35,36 = 26.08; P < 0.0001). Cocaine concentrations began to
increase 5–6 min after probe immersion into the cocaine solution,
and reached near-maximum concentrations 1–2 min later. Thus, the
delay time between the microdialysis probe and the collection vial is
5–6 min, and after this delay, near peak concentrations of cocaine
were detected within 1–2 min. When the microdialysis probes were
placed back into the solution that did not contain cocaine, drug con-
centrations significantly decreased (One-way ANOVA on minutes 0 to
42; F42,43 = 17.51; P < 0.0001). Cocaine concentrations began to
decrease 5–6 min after removal of the probes from the cocaine
solution, and they returned to baseline levels 1–2 min later. Thus,
there was a 5–6-min delay time to detect the presence and then
absence of cocaine in a solution. This delay is the time it takes for
aCSF to be transported across the microdialysis probe membrane,
through the probe outlet tubing and into the collection vial. Residual
cocaine is also removed from the microdialysis probes within 2 min
after this delay time. Based on these findings, the curves illustrating
brain cocaine and dopamine concentrations in vivo (Fig. 3) were
corrected for a 5-min delay time.
Varying the rate of i.v. cocaine delivery between 5 and 90 s
significantly influences striatal cocaine and dopamine Tmax,
but not Cmax
In all seven rats, the unilateral microdialysis probe was located in
the DS between 2.2 and 1.2 mm anterior to Bregma (Fig. 3a). Some
probe tips extended slightly into the nucleus accumbens core. How-
ever, there would be little to no sampling from the probe tips as tips
were occluded with super glue to create a closed system for dialy-
sate flow. All animals received all three intravenous cocaine infu-
sions administered over 5, 45 and 90 s, in counter-balanced order.
Baseline levels of cocaine and dopamine during the 5 min prior to
each infusion were comparable (Cocaine: F2,18 = 1.42, P = 0.27;
Dopamine: F2,18 = 0.15, P = 0.86; data not shown). Thus, cocaine
and dopamine concentrations returned to pre-cocaine baseline levels
before each infusion, and there were no significant carry-over effects
from one infusion to the next. At all rates, i.v. cocaine administra-
tion increased extracellular concentrations of both cocaine and dopa-
mine above baseline (Fig. 3b and c, respectively). The rate of i.v.
cocaine infusion significantly influenced cocaine and dopamine con-
centrations over time (Infusion rate 9 Time interaction effect;
Fig. 3b, F36,216 = 4.38; Fig. 3c, F36,216 = 3.56; all P’s < 0.0001).
There was no significant effect of the rate of i.v. cocaine infusion
on peak concentrations (Cmax values) of cocaine (Fig. 4a;
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F1.61,9.67 = 1.71, P = 0.23; 5 s: 267.82  52.11; 45 s: 223.69 
41.19; 90 s: 185.09  27.18 nM) or dopamine (Fig. 4b F1.41,8.44 =
0.87, P = 0.42; 5 s: 3.50  0.49, 45 s: 3.79  0.82; 90 s:
3.06  0.53 nM). However, as hypothesized, peak concentrations of
cocaine (Fig. 4c; F1.5,9 = 16.23, P = 0.0016; 5–45 s < 90 s; 5 s:
4.33  0.86; 45 s: 6.86  1.28; 90 s: 11.71  0.47 min) and dopa-
mine (Fig. 4d; F1.53,9.17 = 7.34, P = 0.02; 5 < 90 s; 5 s:
4.33  0.42; 45 s: 6.71  0.89; 90 s: 9.29  1.49 min) were
reached earlier following faster i.v. infusions. To further examine
this effect, we analysed the effects of infusion rate on the time inter-
val before cocaine and dopamine concentrations were greater than
baseline concentrations by two standard deviations. This further con-
firmed that a 5-s infusion led to the fastest increases in extracellular
concentrations of cocaine and dopamine (Fig. 4e; F2, 12 = 6.42,
P = 0.01; 5 vs. 90 s: t6 = 2.74, P = 0.03; 45 vs. 90 s: t6 = 2.59,
P = 0.04; Fig. 4f; F2,12 = 4.31, P = 0.04; 5 vs. 90 s: t6 = 2.54,
P = 0.04). In parallel, we observed the animals during testing and
we noted that locomotor activity increased earlier following rapid
(5 s) vs. more sustained (45–90 s) i.v. cocaine infusions.
In summary, at all cocaine i.v. infusion rates, we measured a sig-
nificant increase in drug and dopamine concentrations in the DS.
Increasing the rate of i.v. cocaine delivery between 90 and 5 s did
not significantly influence peak concentrations of the drug or of
dopamine. However, cocaine and dopamine concentrations reached
peak levels earlier following more rapid infusions.
Cocaine and dopamine concentrations are tightly coupled
across time
Data from representative rats show that, at all infusion rates, cocaine
and dopamine concentrations were very closely linked across time
(Figs 5a–c). Across all experimental rats and infusion rates, there
was a significant positive correlation between extracellular cocaine
and dopamine concentrations at each sampling time after drug infu-
sion (Fig. 5d; r2 = 0.77, P < 0.0001). There was also a significant
positive correlation between extracellular cocaine and dopamine
concentrations at each infusion rate (5 s, r2 = 0.61, P = 0.0006;
45 s, r2 = 0.88, P < 0.0001; 90 s, r2 = 0.91, P < 0.0001, Data not
shown). This correlation was stronger following a 90-s infusion
compared to a 5-s infusion (Z = 2.02, P = 0.04; no other compar-
isons were statistically significant). The linear relationship between
cocaine and dopamine was observed up to 187–220 nM cocaine, the
highest concentrations measured following i.v. infusion of the drug
over 5–90 s, respectively.
I.v. cocaine infusion does not significantly influence striatal
levels of other neurochemicals
In addition to dopamine, we also measured extracellular concentra-
tions of 20 other neurochemicals in the striatum after cocaine infu-
sion. These were acetylcholine, adenosine, aspartate, c-aminobutyric
acid, glucose, glutamate, glutamine, glycine, histamine, nore-
pinephrine, phenylalanine, serine, serotonin, taurine, tyrosine and the
metabolites 3,4-dihydroxyphenylacetic acid, homovanillic acid, 3-
methoxytyramine, 5-hydroxyindoleacetic acid and normetanephrine
in the DS. There were no significant effects of cocaine or of the rate
of infusion on the concentrations of any of these (see Figures S1–S3).
Locomotor activity increases earlier when cocaine is infused
over 5 s
I.v. infusion rate did not influence the locomotor response to saline
(Saline; F2,9 = 0.21, P = 0.81). Thus, saline-induced locomotion was
pooled across rates and this served as the control condition. At all
infusion rates, cocaine increased locomotor activity relative to saline
(Fig. 6; F3,33 = 6.80, P = 0.001; 5 s vs. Saline: F1,11 = 11.43,
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P = 0.006; 45 s vs. Saline: F1,11 = 16.24, P = 0.002; 90 s vs. Saline:
F1,11 = 27.74, P = 0.0003), and all rates evoked a comparable
increase in locomotion (One-way ANOVA on total locomotor counts
over the 30 min after cocaine injection; F1.10,12.13 = 2.17, P = 0.17).
However, infusion rate significantly influenced cocaine-induced loco-
motion across time (Infusion rate 9 Time interaction effect;
F68,748 = 1.47, P = 0.01). To analyse this further, we compared loco-
motor activity in the first minute following cocaine injection. This
showed that injecting cocaine i.v. over 5 vs. 90 s evokes greater loco-
motor activity in the first minute post-injection (F1.57,17.24 = 10.87,
P = 0.002; 5 vs. 90 s, P = 0.004).
Discussion
To our knowledge, the present experiment is the first to simultane-
ously measure brain concentrations of extracellular cocaine and
dopamine in awake, freely moving rats, and to also assess the influ-
ence of the rate of i.v. cocaine infusion. We found that injecting
cocaine i.v. between 5 and 90 s robustly increases cocaine and
dopamine concentrations in the DS, without significantly altering
peak concentrations of either analyte (see also Ferrario et al., 2008).
However, drug and dopamine concentrations rose faster when
cocaine was administered over 5 s, such that peak concentrations
were reached earlier. Previous work shows that compared to slower
i.v. cocaine infusions (25–100 s), rapid infusions (5–16 s) promote
the development of sensitization to both the psychomotor activating
and incentive motivational effects of cocaine (Samaha et al., 2002,
2004; Liu et al., 2005; Minogianis et al., 2013; Bouayad-Gervais
et al., 2014; Allain et al., 2017), lead to greater drug intake (Wak-
abayashi et al., 2010; Minogianis et al., 2013; Bouayad-Gervais
et al., 2014), and increase the risk of cocaine-primed relapse follow-
ing extended abstinence (Wakabayashi et al., 2010). Rapid cocaine
delivery to the brain also preferentially engages mesocorticolimbic
cells (Porrino, 1993; Samaha et al., 2004; Brown & Kiyatkin, 2005;
Ferrario et al., 2008). If rapid i.v. cocaine administration promotes
these addiction-relevant effects by changing dopamine neurotrans-
mission, our findings suggest that the critical factor is likely the time
it takes to transition from low/baseline to high extracellular dopa-
mine concentrations rather than any large differences in peak con-
centrations (Ferrario et al., 2008).
Our results confirm predictions derived from pharmacokinetic
modelling. Samaha et al. (2002) used a pharmacokinetic model vali-
dated by Pan et al. (1991) and estimated that injecting cocaine i.v.
over 5, 50 or 100 s would not significantly influence peak brain
concentrations of the drug, but would change the rate of rise of drug
concentrations. Our findings confirm this to be the case. The tempo-
ral profile of brain cocaine concentrations we report also matches
that in Samaha et al. (2002). However, Samaha et al. (2002) esti-
mated higher peak cocaine values in the brain than measured here
(~4 lM after 1 mg/kg i.v. cocaine compared to 0.2–0.26 lM after
2 mg/kg i.v. cocaine here). Samaha et al. (2002) used a pharma-
cokinetic model that estimates whole brain concentrations corrected
for probe recovery rate, while here we report uncorrected concentra-
tions from dialysate samples. Uncorrected concentration values in
dialysate samples would be lower. In accordance with this, in the
present study, an in vitro test showed that peak concentrations of
cocaine detected by the probes were 10-fold lower than the concen-
tration in the prepared solution (0.1–0.14 lM were detected in a 1-
lM cocaine solution). This represents a 10% probe recovery at the
2 lL/min flow rate used here. As such, keeping in mind the 10%
recovery rate from the microdialysis probe, the striatal cocaine and
dopamine values we report can be used to select behaviourally rele-
vant cocaine and dopamine concentrations in in vitro experiments
(Nicolaysen et al., 1988). Indeed, the cocaine dose we used (2 mg/kg)
also produced a robust increase in psychomotor activity (detailed
below).
Variation in the rate of i.v. cocaine infusion significantly influ-
enced the temporal dynamics of cocaine and dopamine levels in the
DS. By sampling at 1-min intervals, we found that peak brain con-
centrations of cocaine were reached 4 min after a 5-s infusion,
7 min after a 45-s infusion and 12 min after a 90-s infusion. Simi-
larly, Hurd et al. (1988), who sampled every 10 min, found that fol-
lowing an 85-s i.v. cocaine infusion, peak drug concentrations in the
striatum are seen within the first 10-min sample. The cocaine Tmax
values we observed here after a 5- vs. 90-s i.v. infusion are also
generally similar to those seen in rats following i.v. (1–2 min) and
intranasal (15 min) cocaine administration, respectively (Chow
et al., 1999). This suggests that injecting cocaine i.v. over 5 vs.
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90 s in rats can to some extent model the temporal kinetics of i.v.
vs. intranasal cocaine. Our findings also agree with those of Ferrario
et al. (2008) showing that infusing cocaine i.v. between 5 and 90 s
does not produce large effects on peak dopamine concentrations in
the striatum (or on area under the curve values for dopamine), but it
produces significant differences in dopamine Tmax. Ferrario et al.
(2008) also reported that dopamine concentrations start to rise 1–
2 min after a 5-s i.v. cocaine infusion, and 3–3.5 min after a 100-s
infusion. Similarly, here we found that dopamine concentrations
begin to increase 1 min after a 5-s cocaine infusion, and 5 min after
a 90-s infusion. We have previously used in vivo voltammetry tech-
niques in urethane-anaesthetized rats and found that peak levels of
dopamine reuptake inhibition occur within 1 min after a 5-s i.v.
cocaine infusion (Samaha et al., 2004). This is much sooner than
the time to reach peak brain concentrations of dopamine we
observed here using awake, freely moving animals and in vivo
microdialysis (4 min after a 5-s infusion). However, our findings
agree with those of others using in vivo voltammetry techniques in
awake, freely moving rats, and showing that peak dopamine inhibi-
tion does not occur until 6 min after a 12–15 s i.v. cocaine infusion
(Kiyatkin et al., 2000). The reasons for the discrepancy between
these findings could involve the use of anaesthetized vs. awake
animals. It is also possible that there is a non-linear relationship
between the ability of an i.v. infusion of cocaine to occupy dopa-
mine transporters and its ability to block the reuptake of dopamine,
and thus increase dopamine overflow (Brodnik et al., 2017).
Brain cocaine and dopamine concentrations were tightly coupled
across time, at all infusion rates. This agrees with previous studies
where cocaine was given via the intraperitoneal or i.v. routes (Nico-
laysen et al., 1988; Shou et al., 2006). Thus, once in the brain,
cocaine quickly occupies dopamine transporters, producing rapid
dopamine reuptake blockade and overflow into the extracellular
space. The cocaine-induced increases in dopamine concentrations
we measured here are likely largely due to blockade of the dopa-
mine transporter, but cocaine could also be altering dopamine
release (Venton et al., 2006; Mejias-Aponte et al., 2015). As this
matter is resolved, the very close temporal relationship between
brain cocaine and dopamine concentrations we observed suggests
that the pharmacokinetic profile of one compound can be used as a
proxy for the other.
In contrast with what we observed with dopamine, acute i.v.
cocaine injections did not change the concentrations of other neuro-
chemicals in the striatum. We tested only one (albeit relatively high)
dose of cocaine. In addition, our rats received a total of three
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cocaine infusions. This might not be sufficient to reliably alter extra-
cellular concentrations of some of the compounds we measured. For
instance, several exposures to cocaine are generally needed to signif-
icantly increase striatal glutamate concentrations (Zhang et al.,
2001). Interestingly, here and in prior work (Hurd & Ungerstedt,
1989), cocaine did not significantly change dopamine metabolite
concentrations (DOPAC, HVA and 3-MT), even though the drug
robustly increased extracellular dopamine concentrations. This sug-
gests that the relationship between dopamine release and metabolism
is not simple. Cocaine might not significantly change dopamine
metabolite concentrations in the DS because the drug potently
blocks dopamine reuptake, thus preventing dopamine metabolism in
the cell terminal (Hurd & Ungerstedt, 1989). Although acute cocaine
can significantly increase norepinephrine overflow in the ventral
striatum (Reith et al. 1997), we found no effects on norepinephrine
overflow in the DS. To our knowledge, this is the first report on
how systemic cocaine administration influences norepinephrine over-
flow in the DS. The DS contains a limited density of scattered nora-
drenergic axons and very little norepinephrine (Fornai et al., 1996).
We also saw no effect of i.v. cocaine on serotonin concentrations in
the DS. This was surprising as cocaine has similar affinities for
brain serotonin and dopamine transporters (Miller et al., 2001; Roth-
man et al., 2001). Others have reported that acute cocaine increases
extracellular concentrations of serotonin in the dorsal (Bradberry
et al., 1993) and ventral (Essman et al., 1994) striatum. The dis-
crepancy between our findings and these reports could be due to the
use of anaesthetized rats (Bradberry et al., 1993), the route of
cocaine administration (Bradberry et al., 1993) and the striatal sub-
region sampled (Essman et al., 1994).
The rate of cocaine infusion also influenced the temporal dynam-
ics of psychomotor activity. Although i.v. infusion rate did not sig-
nificantly influence total levels of cocaine-induced locomotion,
faster i.v. infusions evoked a greater locomotor response in the first
minute after infusion. Thus, the rate of cocaine infusion influenced
the temporal dynamics of both dopamine concentrations and drug-
induced psychomotor activity. However, the relationship between
these two measures is not straightforward. First, at all infusion rates,
cocaine-induced locomotion both peaked earlier and returned to
baseline levels sooner than drug or dopamine concentrations (com-
pare Figs 6 and 3). We measured cocaine/dopamine concentrations
and cocaine-induced locomotor activity in different animals. How-
ever, others have taken the two measures in the same animals and
also found that in previously drug-naive rats, cocaine-induced loco-
motion peaks earlier than cocaine-induced dopamine concentrations
(Kalivas & Duffy, 1990, but see Hemby et al., 1994). Other studies
with methylphenidate (Gerasimov et al., 2000) or nicotine (Benwell
& Balfour, 1992) also show a similar effect. Combined, the present
study and these prior reports have measured drug-induced dopamine
overflow in both the dorsal and ventral striatum. Thus, it is possible
that drug-induced dopamine accumulation outside of these brain
regions also significantly contributes to the psychomotor response
(Kalivas & Duffy, 1990). It is also possible that cocaine increases
dopamine concentrations in the synapse to induce psychomotor
activity, without proportionate or immediate diffusion of dopamine
outside of the synapse, to the microdialysis probe (Gonon, 1988;
Kalivas & Duffy, 1990). This would explain why cocaine-induced
dopamine concentrations detected by the probe peak later in time
compared to cocaine-induced locomotion.
There are elements to consider in interpreting our findings. First,
we do not know how the rate of i.v. cocaine infusion influences
cocaine/dopamine pharmacokinetics in extra-striatal brain regions.
We would predict that the cocaine pharmacokinetics we measured in
the DS likely reflect those in the rest of the brain. Indeed, cocaine is
distributed uniformly in the brain following i.v. or intranasal admin-
istration (Reed & Spiehler, 1985). A Positron Emission Tomography
study in humans also suggests that drug pharmacokinetics in indi-
vidual brain regions are very similar to those in whole brain (Ber-
ridge et al., 2010). Second, the neurobehavioural effects of cocaine
that are relevant to addiction come about following chronic exposure
to the drug. We do not know how our measurements would change
with more extensive drug exposure. Of note, brain and blood con-
centrations of cocaine do not significantly change following repeated
i.v. administration (Pan et al., 1991). However, i.v. cocaine-induced
inhibition of dopamine reuptake can increase with repeated exposure
(Brodnik et al., 2017). This being said, studying brain cocaine and
dopamine pharmacokinetics after a single cocaine exposure is
important. A single exposure to psychostimulant drugs like cocaine
or d-amphetamine can produce effects that are relevant to the addic-
tion process, in both laboratory rats and humans. These effects
include psychomotor sensitization (Robinson et al., 1982; Lin-Chu
et al., 1985; Strakowski & Sax, 1998; Samaha et al., 2002) and
changes in spine density on medium spiny neurons of the nucleus
accumbens (Kolb et al., 2003). Finally, we only tested a single
cocaine dose, but we would predict that, across a range of cocaine
doses, varying the rate of i.v. drug infusion changes the rate of rise
of drug concentrations in the brain.
In summary, we measured striatal concentrations of cocaine and
dopamine, as well as cocaine-induced locomotion across a range of
i.v. infusion rates that significantly influences brain and behaviour
(Reviewed in Samaha & Robinson, 2005; Allain et al., 2015). We
found that increasing the rate of i.v. drug delivery increases the rate
of rise of cocaine and dopamine concentrations in the DS, without
producing large effects in peak concentrations. This was linked to a
more immediate increase in locomotor activity following rapid vs.
slower i.v. cocaine infusions. Thus, our results raise the possibility
that differences in the rate of cocaine rise alone can determine out-
come, perhaps by influencing the temporal dynamics of dopamine
accumulation in the synapse, and the temporal pattern of dopamine
receptor occupancy. In support of this, work in humans shows that
smoked and intranasal cocaine can produce equivalent levels of
dopamine transporter blockade, but smoked cocaine produces a
stronger self-reported high (Volkow et al., 2000). Thus, we con-
clude that differences in the rate of rise of drug and dopamine levels
in the brain might be an important issue in thinking about why
drugs, formulations and routes of administration that achieve a rapid
drug onset are the most addictive.
Supporting Information
Additional supporting information may be found online in the Sup-
porting Information section at the end of the article:
Fig. S1. Cocaine had no significant effect on non-dopaminergic neu-
rotransmitters in the dorsal striatum.
Fig. S2. Cocaine had no significant effect on neuromodulators in the
dorsal striatum.
Fig. S3. Cocaine had no significant effect on neurotransmitter
metabolites in the dorsal striatum.
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